Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / settlement-financial-impact-analysis.xlsx
settlement-financial-impact-analysis.xlsx
High · 1
Medium · 0
Standard · 0
[sheet: Settlement Summary]
High
⚑ Penalty / liquidated damages
[sheet: Settlement Summary] Item | Amount / Detail | Notes Client | Penterra Pharmaceuticals Corp. (EIN: 22-3741856) | Nasdaq: PPCA Matter Number | 1018-00009 | Calderwood & Harkness LLP Tax Years at Issue | 2017, 2018, 2019, 2020 | Forms 1120 IRS Exam Team ID | LB&I-NE-TP-2022-00641 | LB&I Northeast Transfer Pricing Practice NOPA Date | October 12, 2023 | All four tax years 30-Day Letter Date | November 8, 2023 Form